Voloridge Investment Management, LLC Solid Biosciences Inc. Transaction History

Voloridge Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.1 - $3.42 $47,709 - $77,698	-22,719 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.31 - $4.43 $52,480 - $100,645	22,719 New	22,719 $54,000
Q2 2019 Aug 14, 2019	SELL	$4.6 - $10.13 $205,067 - $451,595	-44,580 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.19 - $32.37 $320,530 - $1.44 Million	44,580 New	44,580 $410,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.